Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?-Reference-Cited by-同舟云学术

Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?

Published:2015-11 Issue:17 Volume:29 Page:2323-2333
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Jarrin Inma,Pantazis Nikos,Dalmau Judith,Phillips Andrew N.,Olson Ashley,Mussini Cristina,Boufassa Faroudy,Costagliola Dominique,Porter Kholoud,Blanco Juliá,Del Amo Julia,Martinez-Picado Javier

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference30 articles.

1. CASCADE Collaboration in EuroCoord. An evaluation of HIV elite controller definitions within a large seroconverter cohort study.;Olson;PLoS One,2014

2. CASCADE Collaboration in EuroCoord. Evaluation of rapid progressors in HIV infection as an extreme phenotype.;Olson;J Acquir Immune Defic Syndr,2014

3. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.;Pereyra;J Infect Dis,2008

4. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.;Science,2010

5. Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque.;Rotger;J Clin Invest,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Mechanism of HIV-1 Immune Reconstitution Failure: Understanding Lymphocyte Subpopulations and Interventions for Immunological Nonresponders;The Journal of Immunology;2024-06-01

2. Trends and the associated factors of optimal immunological response and virological response in late anti-retroviral therapy initiation HIV cases in Taiwan from 2009 to 2020;Journal of Infection and Public Health;2024-02

3. Immunological inefficiency of art in HIV-infected patients;HIV Infection and Immunosuppressive Disorders;2023-07-20

4. CD4+ T lymphocyte recovery in the modern antiretroviral therapy era: Toward a new threshold for defining immunological non-responders;Frontiers in Virology;2023-01-10

5. The Characteristics of the HIV-1 Env Glycoprotein Are Linked With Viral Pathogenesis;Frontiers in Microbiology;2022-03-24